Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Olba Healthcare Holdings's quarterly finished goods
increased
from Jun. 2025 (円6,417 Mil) to Sep. 2025 (円7,001 Mil) and
increased
from Sep. 2025 (円7,001 Mil) to Dec. 2025 (円7,396 Mil).
Olba Healthcare Holdings's annual finished goods
declined
from Jun. 2023 (円6,161 Mil) to Jun. 2024 (円5,943 Mil) but then
increased
from Jun. 2024 (円5,943 Mil) to Jun. 2025 (円6,417 Mil).
Olba Healthcare Holdings Inventories, Finished Goods Historical Data
* Premium members only.
The historical data trend for Olba Healthcare Holdings's Inventories, Finished Goods can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Inventories, Finished Goods of 円7,396 Mil mean?
Olba Healthcare Holdings (TSE:2689) has a Inventories, Finished Goods of 円7,396 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Olba Healthcare Holdings and its competitors.
Is Olba Healthcare Holdings' Inventories, Finished Goods too high?
Olba Healthcare Holdings' current Inventories, Finished Goods is 円7,396 Mil. Overall, Olba Healthcare Holdings has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Olba Healthcare Holdings' Inventories, Finished Goods compare to MCK and COR?
Olba Healthcare Holdings' Inventories, Finished Goods of 円7,396 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Distribution company?
A good Inventories, Finished Goods depends on the Medical Distribution industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Olba Healthcare Holdings and its competitors. Olba Healthcare Holdings's current Inventories, Finished Goods is 円7,396 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Olba Healthcare Holdings (TSE:2689) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,619.26, compared to a current price of 円1,901.00 — trading 17.4% above its estimated fair value. The current Inventories, Finished Goods is 円7,396 Mil. Olba Healthcare Holdings' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Olba Healthcare Holdings (TSE:2689), the current Inventories, Finished Goods is 円7,396 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba Healthcare Holdings (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba Healthcare Holdings stock appears to be overvalued.
The current stock price of 円1,901.00 is trading 17.4% above its estimated GF Value™ of 円1,619.26.
GuruFocus considers Olba Healthcare Holdings to be Modestly Overvalued.
Key valuation signals for TSE:2689:
Inventories, Finished Goods: 円7,396 Mil
GF Value™: 円1,619.26 vs. price of 円1,901.00 (17.4% above fair value)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
63GF Score
Get the complete analysis for TSE:2689
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
